查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1901531

分子诊断市场：依产品、技术、应用、最终用户、国家及地区划分－全球产业分析、市场规模、市场占有率及2025-2032年预测

Molecular Diagnostics Market, By Product, By Technology, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年分子诊断市场规模为 254.5689 亿美元，从 2025 年到 2032 年将以 4.1% 的复合年增长率成长。

受精准、快速、早期疾病检测需求不断增长的推动，分子诊断市场正经历强劲成长。 PCR、NGS、ISH、微阵列和等温扩增等技术被广泛应用于传染病、癌症、遗传疾病的诊断以及血液筛检。爱滋病、新冠肺炎、结核病和各种癌症等疾病的日益普及持续推动着检测的普及。伴随诊断、个人化医疗和药物基因组学等领域的应用不断拓展，进一步巩固了市场扩张。然而，分子诊断市场也面临许多限制因素，例如高昂的检测和设备成本、复杂的监管审批流程等等。

分子诊断市场－市场动态

传染病和癌症发生率不断上升

分子诊断技术，特别是聚合酶炼式反应（PCR）、即时PCR和等温扩增技术，即使在病毒或细菌量极低的情况下，也能早期辨识病原体。这有助于及时制定治疗方案、控制疫情爆发并有效管理患者。此外，病毒新变种的出现和抗菌素抗药性的增加进一步加剧了对分子层面检测的依赖。传染病和癌症的日益普及是推动分子诊断市场成长的主要动力。爱滋病、B型和丙型肝炎、结核病、流感、呼吸道感染以及新出现的病毒威胁等传染病需要快速、准确和灵敏的检测方法。根据世界卫生组织发布的资料，截至2024年底，全球估计有4,080万人感染爱滋病毒，其中包括3,940万成年人和140万儿童。当年，全球约有130万人感染爱滋病毒。此外，2024 年约有 63 万人死于爱滋病相关疾病，比 2010 年减少了 54%。因此，日益加重的疾病负担、对早期检测的需求以及精准医疗应用的不断扩展，正在显着加速全球分子诊断技术的普及。

分子诊断市场細項分析：

全球分子诊断市场按产品、技术、应用、最终用户和地区进行细分。

依产品类型，市场可分为三大类：试剂盒、仪器系统和软体服务。试剂盒因其检测频率高而占据主导地位；仪器系统支援自动化和高精度检测；软体服务则可实现高效的资料分析、工作流程管理和系统整合。

根据技术类型，市场可分为六大类：PCR、次世代定序 (NGS)、原位杂交、晶片和微阵列、质谱以及其他技术。 NGS 可实现基因组分析；原位杂交可提供空间分析；微阵列和质谱可提高多重检测能力和精确度；而其他技术则支援专业化和新兴的诊断应用。

分子诊断市场—地理洞察

北美凭藉着先进的医疗基础设施、PCR和NGS技术的高普及率、大型企业的强大影响力以及健全的医保报销体系，引领市场。欧洲紧随其后，其成长主要得益于癌症诊断、传染病检测的普及以及政府对精准医疗的支持。亚太地区是成长最快的地区，这得益于医疗服务覆盖范围的扩大、慢性病负担的加重、庞大的患者群体，以及中国、印度和日本等国家在基因组学和实验室自动化领域不断增加的投资。拉丁美洲的成长较为温和，主要得益于诊断能力的提升和公共卫生计画的扩展。中东和非洲仍是新兴市场，其成长受到成本限制，但医疗基础设施的逐步改善和传染病筛检措施的推进为其提供了支撑。

分子诊断市场－各国概况

美国分子诊断市场呈现显着的复合年增长率。这一增长主要得益于诊断技术的进步、对个人化医疗日益增长的需求以及美国传染病和癌症发病率的上升。美国医疗保健系统对疾病早期检测和精准医疗的重视，促进了分子诊断在医院、诊断中心和研究机构的广泛应用。液体活检和新一代定序（NGS）等关键技术正被越来越多地用于提高诊断准确性和标靶治疗选择，尤其是在肿瘤学领域。此外，新冠肺炎、流感和爱滋病等传染病的日益普及也推动了对快速、准确的分子检测的需求。

目录

第一章：分子诊断市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
  • 竞争洞察

第三章：分子诊断市场主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章：分子诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：分子诊断市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：分子诊断市场概况

  • 分子诊断市占率分析，2024年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：分子诊断市场：依产品划分

  • 概述
    • 细分市场占有率分析：依产品划分
    • 试剂和试剂盒
    • 仪器与系统
    • 软体与服务

第八章：分子诊断市场：依技术划分

  • 概述
    • 细分市场占有率分析：依技术划分
    • PCR
    • 下一代定序（NGS）
    • 原位杂交
    • 晶片与微阵列
    • 质谱分析
    • 其他技术

第九章：分子诊断市场：依应用划分

  • 概述
    • 细分市场占有率分析：按应用
    • 肿瘤学
      • 乳癌
      • 摄护腺癌
      • 大肠直肠癌
      • 其他的
    • 传染病
      • 呼吸道感染
      • 性传染感染
      • 血液传染感染
      • 结核分枝桿菌和非结核分枝桿菌
      • 其他的
    • 药物基因组学
    • 微生物学
    • 遗传疾病筛检
    • 人类白血球抗原分型
    • 血液筛检
    • 其他的

第十章：分子诊断市场：依最终用户划分

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院
    • 诊断与参考实验室
    • 学术与研究机构
    • 其他最终用户

第十一章：分子诊断市场：依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十二章：主要供应商分析：分子诊断产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • BD
    • Abbott
    • F. Hoffmann-La Roche, Ltd.
    • Agilent Technologies, Inc.
    • Danaher Corporation
    • Siemens Healthineers AG
    • Agilent Technologies Inc.
    • Hologic Inc. (Gen Probe)
    • Sysmex Corporation
    • Illumina Inc.
    • Others

第十三章：360度AnalystView

简介目录
Product Code: ANV5865

The Molecular Diagnostics Market size was valued at US$ 25,456.89 Million in 2024, expanding at a CAGR of 4.1% from 2025 to 2032.

The molecular diagnostics market is experiencing strong growth driven by rising demand for precise, rapid, and early disease detection. Technologies such as PCR, NGS, ISH, microarrays, and isothermal amplification are widely used for diagnosing infectious diseases, cancer, genetic disorders, and for blood screening. Increasing prevalence of conditions like HIV, COVID-19, tuberculosis, and various cancers continues to boost test adoption. Growing applications in companion diagnostics, personalized medicine, and pharmacogenomics further strengthen market expansion. However, the Molecular diagnostics market faces restraints such as high test and equipment costs, complex regulatory approvals, and others.

Molecular Diagnostics Market- Market Dynamics

Rising prevalence of infectious diseases and cancers

Molecular diagnostics, especially PCR, real-time PCR, and isothermal amplification, allow early identification of pathogens, even at very low viral or bacterial loads. This supports timely treatment decisions, outbreak control, and effective patient management. Additionally, new variants of viruses and antimicrobial resistance trends further increase dependence on molecular-level testing. The rising prevalence of infectious diseases and cancers is a major force driving the growth of the molecular diagnostics market. Infectious diseases such as HIV, hepatitis B and C, tuberculosis, influenza, respiratory infections, and emerging viral threats require rapid, accurate, and sensitive detection methods. According to the data published by the World Health Organization, at the end of 2024, an estimated 40.8 million people worldwide were living with HIV, including 39.4 million adults and 1.4 million children. In that year, about 1.3 million people acquired HIV globally. Additionally, around 630,000 people died from AIDS-related illnesses in 2024, marking a 54% reduction in AIDS-related deaths since 2010. Thus, growing disease burden, need for early detection, and expanding precision medicine applications are significantly accelerating the adoption of molecular diagnostics worldwide.

Molecular Diagnostics Market- Segmentation Analysis:

The Global Molecular Diagnostics Market is segmented on the basis of Product, Technology, Application, End User, and Region.

The market is divided into three categories based on Product: Reagents & Kits, Instruments & Systems, and Software & Services. Reagents & kits dominate due to high testing frequency, while instruments & systems support automation and accuracy, and software & services enable efficient data analysis, workflow management, and integration.

The market is divided into six categories based on Technology: PCR, Next-Generation Sequencing (NGS), In Situ Hybridization, Chips & Microarrays, Mass Spectrometry, and Other Technologies. NGS enables genomic profiling; In situ Hybridization offers spatial analysis; microarrays and mass spectrometry enhance multiplexing and precision, while other technologies support specialised and emerging diagnostic applications.

Molecular Diagnostics Market- Geographical Insights

North America leads the market due to advanced healthcare infrastructure, high adoption of PCR and NGS technologies, strong presence of major companies, and robust reimbursement systems. Europe follows closely, driven by rising cancer diagnostics, infectious disease testing, and government support for precision medicine. Asia-Pacific is the fastest-growing region, supported by expanding healthcare access, rising chronic disease burden, large patient populations, and increasing investments in genomics and laboratory automation in countries like China, India, and Japan. Latin America shows moderate growth, driven by improving diagnostic capacity and expanding public health programs. Middle East & Africa remain emerging markets, with growth limited by cost constraints but supported by gradual improvements in healthcare infrastructure and infectious disease screening initiatives.

Molecular Diagnostics Market- Country Insights

The United States molecular diagnostics market was reflecting a significant CAGR. This growth is primarily driven by advancements in diagnostic technologies, increasing demand for personalised medicine, and a rising incidence of infectious diseases and cancer in the country. The U.S. healthcare system's focus on early disease detection and precision medicine contributes to the widespread adoption of molecular diagnostics across hospitals, diagnostic centres, and research institutions. Key technologies such as liquid biopsy and next-generation sequencing (NGS) are increasingly utilised to enhance diagnostic accuracy and targeted therapy selection, especially in oncology. Additionally, the rising prevalence of infectious diseases like COVID-19, influenza, and HIV fuels demand for rapid and accurate molecular testing.

Molecular Diagnostics Market- Competitive Landscape:

The molecular diagnostics market's competitive landscape in 2025 is led by several major global players that drive innovation and market growth through robust product portfolios, technological advancements, and strategic expansions. For instance, in August 2024, Sysmex Corporation expanded its strategic alliance with QIAGEN to deepen collaboration in genetic testing, covering research and development, production, clinical trials, and global sales and marketing. This alliance builds upon their initial 2021 partnership focused on cancer companion diagnostics using ultra-sensitive liquid biopsy NGS technology. Additionally, the market players are actively engaged in regulatory approvals, acquisitions, and partnerships to enhance their market presence. Moreover, the collaborative efforts of market players, coupled with continuous R&D, enable the molecular diagnostics market to grow robustly, addressing diverse clinical needs globally.

Recent Developments:

In March 2025, Danaher Corporation, through subsidiaries like Beckman Coulter, is investing in automated and high-throughput molecular diagnostic solutions to support diverse clinical needs.

In February 2023, Becton Dickinson (BD) received FDA Emergency Use Authorisation (EUA) for a molecular diagnostic test capable of detecting and differentiating COVID-19, influenza A/B, and respiratory syncytial virus (RSV). This test, designed for use on the BD MAX Molecular Diagnostic System, uses a single nasal or nasopharyngeal swab sample.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BD
  • Abbott
  • F. Hoffmann-La Roche, Ltd.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Agilent Technologies Inc.
  • Hologic Inc. (Gen Probe)
  • Sysmex Corporation
  • Illumina Inc.
  • Others

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Kits
  • Instruments & Systems
  • Software & Services

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR
  • Next-Generation Sequencing (NGS)
  • In Situ Hybridization
  • Chips & Microarrays
  • Mass Spectrometry
  • Other Technologies

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
  • Infectious Disease
  • Respiratory Infections
  • Sexually Transmitted Infections
  • Blood-borne Infections
  • Tuberculosis & Non-tuberculous Mycobacteria
  • Others
  • Pharmacogenomics
  • Microbiology
  • Genetic Disease Screening
  • Human Leukocyte Antigen Typing
  • Blood Screening
  • Others

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic & Reference Laboratories
  • Academic & Research Institutes
  • Other End Users

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Diagnostics Market Snippet by Product
    • 2.1.2. Molecular Diagnostics Market Snippet by Technology
    • 2.1.3. Molecular Diagnostics Market Snippet by Application
    • 2.1.4. Molecular Diagnostics Market Snippet by End User
    • 2.1.5. Molecular Diagnostics Market Snippet by Country
    • 2.1.6. Molecular Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Diagnostics Key Market Trends

  • 3.1. Molecular Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Diagnostics Market Opportunities
  • 3.4. Molecular Diagnostics Market Future Trends

4. Molecular Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Diagnostics Market Landscape

  • 6.1. Molecular Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Reagents & Kits
    • 7.1.3. Instruments & Systems
    • 7.1.4. Software & Services

8. Molecular Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. PCR
    • 8.1.3. Next-Generation Sequencing (NGS)
    • 8.1.4. In Situ Hybridization
    • 8.1.5. Chips & Microarrays
    • 8.1.6. Mass Spectrometry
    • 8.1.7. Other Technologies

9. Molecular Diagnostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Oncology
      • 9.1.2.1. Breast Cancer
      • 9.1.2.2. Prostate Cancer
      • 9.1.2.3. Colorectal Cancer
      • 9.1.2.4. Others
    • 9.1.3. Infectious Disease
      • 9.1.3.1. Respiratory Infections
      • 9.1.3.2. Sexually Transmitted Infections
      • 9.1.3.3. Blood-borne Infections
      • 9.1.3.4. Tuberculosis & Non-tuberculous Mycobacteria
      • 9.1.3.5. Others
    • 9.1.4. Pharmacogenomics
    • 9.1.5. Microbiology
    • 9.1.6. Genetic Disease Screening
    • 9.1.7. Human Leukocyte Antigen Typing
    • 9.1.8. Blood Screening
    • 9.1.9. Others

10. Molecular Diagnostics Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic & Reference Laboratories
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Other End Users

11. Molecular Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Molecular Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Molecular Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Molecular Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Molecular Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Molecular Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. BD
    • 12.2.2. Abbott
    • 12.2.3. F. Hoffmann-La Roche, Ltd.
    • 12.2.4. Agilent Technologies, Inc.
    • 12.2.5. Danaher Corporation
    • 12.2.6. Siemens Healthineers AG
    • 12.2.7. Agilent Technologies Inc.
    • 12.2.8. Hologic Inc. (Gen Probe)
    • 12.2.9. Sysmex Corporation
    • 12.2.10. Illumina Inc.
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us